Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
9.34
-0.16 (-1.68%)
At close: Feb 20, 2026, 4:00 PM EST
9.16
-0.18 (-1.93%)
After-hours: Feb 20, 2026, 4:00 PM EST

Instil Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6212550822,206-
Market Cap Growth
-57.24%151.37%-39.38%-96.29%--
Enterprise Value
6789-48-1511,691-
Last Close Price
9.1619.097.6212.60342.20-
PB Ratio
0.520.740.220.233.97-
P/TBV Ratio
0.520.740.220.234.09-
Debt / Equity Ratio
0.710.510.380.22--
Net Debt / Equity Ratio
0.04-0.16-0.29-0.50-0.82-0.83
Net Debt / EBITDA Ratio
-0.090.470.760.922.987.66
Net Debt / FCF Ratio
-0.130.480.640.692.523.01
Asset Turnover
-----0.00
Quick Ratio
13.9814.3514.348.0310.9818.20
Current Ratio
34.4515.7615.238.2211.2218.53
Return on Equity (ROE)
-50.60%-37.51%-52.96%-48.58%-37.00%-25.12%
Return on Assets (ROA)
-14.91%-12.72%-14.01%-23.60%-20.89%-12.11%
Return on Capital Employed (ROCE)
-28.00%-23.50%-28.70%-45.90%-27.30%-10.40%
Earnings Yield
-120.85%-59.51%-314.94%-272.97%-7.11%-
FCF Yield
-64.55%-44.71%-207.21%-323.82%-8.16%-
Buyback Yield / Dilution
-1.53%-0.10%-0.44%-22.19%-562.55%-62.05%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q